Flood, D. et al | 2021| The state of diabetes treatment coverage in 55 low-income and middle-income countries: a cross-sectional study of nationally representative, individual-level data in 680 102 adults | The Lancet Healthy Longevity | https://www.thelancet.com/journals/lanhl/article/PIIS2666-7568(21)00089-1/fulltext
This cross-sectional cohort study is the largest assessment of comprehensive diabetes treatment using individual-level data from nationally representative samples of adults across low-income and middle-income countries (LMICs) of diverse income groups and geographical regions.
- Less than one in ten people with diabetes in LMICs receive comprehensive diabetes treatment as recommended by WHO; scaling up the capacity of health systems to deliver treatment not only to lower glucose but also to address cardiovascular disease risk factors, such as hypertension and high cholesterol, are urgent global diabetes priorities.
- The authors make cross-country estimates of diabetes treatment that could be used by health systems in LMICs to benchmark current and future performance
- They report individual characteristics such as young age and lower body-mass index that are associated with low coverage of diabetes treatment; these individual-level findings can be used by health systems to direct care to underserved groups.
The authors findings suggest that improving access to comprehensive treatment not only to lower glucose but also to address cardiovascular disease risk factors such as hypertension and elevated cholesterol are global diabetes priorities.
Paper available in full from The Lancet Healthy Longevity